Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Accumulated Expenses (2016 - 2025)

Dexcom (DXCM) has disclosed Accumulated Expenses for 16 consecutive years, with $169.2 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 51.07% to $169.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $169.2 million through Dec 2025, up 51.07% year-over-year, with the annual reading at $169.2 million for FY2025, 51.07% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $169.2 million at Dexcom, down from $170.2 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $171.0 million in Q4 2023, with the low at $81.4 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $119.8 million, with a median of $112.4 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses tumbled 34.5% in 2024, then skyrocketed 60.87% in 2025.
  • Over 5 years, Accumulated Expenses stood at $125.2 million in 2021, then increased by 7.27% to $134.3 million in 2022, then grew by 27.33% to $171.0 million in 2023, then crashed by 34.5% to $112.0 million in 2024, then soared by 51.07% to $169.2 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $169.2 million, $170.2 million, and $129.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.